Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment

Victoria C. Yan, Florian L. Muller

Research output: Contribution to journalReview articlepeer-review

117 Scopus citations

Abstract

While remdesivir has garnered much hope for its moderate anti-Covid-19 effects, its parent nucleoside, GS-441524, has been overlooked. Pharmacokinetic analysis of remdesivir evidences premature serum hydrolysis to GS-441524; GS-441524 is the predominant metabolite reaching the lungs. With its synthetic simplicity and in vivo efficacy in the veterinary setting, we contend that GS-441524 is superior to remdesivir for Covid-19 treatment.

Original languageEnglish (US)
Pages (from-to)1361-1366
Number of pages6
JournalACS Medicinal Chemistry Letters
Volume11
Issue number7
DOIs
StatePublished - Jul 9 2020

Keywords

  • Covid-19
  • Prodrug
  • drug delivery
  • metabolism
  • remdesivir

ASJC Scopus subject areas

  • Biochemistry
  • Drug Discovery
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment'. Together they form a unique fingerprint.

Cite this